Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688026's Forward Dividend Yield % is ranked worse than 86.86% of 312
companies
in the Medical Devices & Instruments industry
Industry Median: 2.115
vs SHSE:688026: 0.59
During the past 12 months, Guangzhou Jet Biofiltration Co's average Dividends Per Share Growth Rate was 1.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -50.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -26.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Guangzhou Jet Biofiltration Co was -5.80% per year. The lowest was -50.40% per year. And the median was -41.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Guangzhou Jet Biofiltration Co (SHSE:688026) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Guangzhou Jet Biofiltration Co Forward Dividend Yield % Related Terms
SHSE:688026 vs ISRG, BDX, MDLN: Forward Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou Jet Biofiltration Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Jet Biofiltration Co Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou Jet Biofiltration Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Guangzhou Jet Biofiltration Co's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.59% mean?
Guangzhou Jet Biofiltration Co (SHSE:688026) has a Forward Dividend Yield % of 0.59% as of Jul. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Guangzhou Jet Biofiltration Co and its competitors. According to the industry distribution chart, Guangzhou Jet Biofiltration Co ranks #271 out of 312 companies in the Medical Devices & Instruments industry, placing it in the top 86.9%.
Is Guangzhou Jet Biofiltration Co's Forward Dividend Yield % too high?
Guangzhou Jet Biofiltration Co's current Forward Dividend Yield % is 0.59%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.12. Guangzhou Jet Biofiltration Co's value of 0.59% is 72.1% below this industry median. Based on the distribution chart, Guangzhou Jet Biofiltration Co ranks #271 out of 312 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's Forward Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou Jet Biofiltration Co ranks #271 out of 312 companies for Forward Dividend Yield %. This places Guangzhou Jet Biofiltration Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.12. Guangzhou Jet Biofiltration Co's value of 0.59% is 72.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.12, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Jet Biofiltration Co's current Forward Dividend Yield % of 0.59% is 72.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Guangzhou Jet Biofiltration Co and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Jet Biofiltration Co's current Forward Dividend Yield % is 0.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.12, compared to a current price of ¥12.20 — trading 32.7% below its estimated fair value. The current Forward Dividend Yield % is 0.59% and 72.1% below the Medical Devices & Instruments industry median of 2.12. Guangzhou Jet Biofiltration Co's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current Forward Dividend Yield % is 0.59% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be undervalued.
The current stock price of ¥12.20 is trading 32.7% below its estimated GF Value™ of ¥18.12.
GuruFocus considers Guangzhou Jet Biofiltration Co to be Possible Value Trap.
Key valuation signals for SHSE:688026:
Forward Dividend Yield %: 0.59%
GF Value™: ¥18.12 vs. price of ¥12.20 (32.7% below fair value)
Industry Position: 72.1% below the Medical Devices & Instruments median (#271 of 312)
No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Jet Biofiltration Co Business Description
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
68GF Score
Get the complete analysis for SHSE:688026
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688026 has been successfully added to your 
